SCHEMBL3894497

SCHEMBL3894497

C[Si](C)(C)Oc1ccc(Br)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.42
MAPT P10636 3/20 0.41
ALDH1A1 P00352 3/20 0.39
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
RAB9A P51151 3/20 0.39
NPSR1 Q6W5P4 2/20 0.39
MAPK1 P28482 2/20 0.39
LMNA P02545 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
LDHA P00338 1/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
NPC1 O15118 1/20 0.34
GAA P10253 1/20 0.34
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL667750 0.97 CYP2A6 (0.40) CYP2A6MAPTALDH1A1MEN1KMT2A
SCHEMBL10528634 0.93 MAPK1 (0.42) CYP2A6MAPTALDH1A1MEN1KMT2A
SCHEMBL4763549 0.86 CA1 (0.39) ALDH1A1MEN1KMT2AMAPK1CA1
SCHEMBL7688488 0.84 LMNA (0.65) MAPTMEN1KMT2ARAB9ANPSR1
SCHEMBL7688132 0.84 MAPT (0.42) MAPTMEN1KMT2ARAB9ANPSR1
SCHEMBL10951164 0.80 CYP2A6 (0.38) CYP2A6MAPTALDH1A1MEN1KMT2A
SCHEMBL8171076 0.80 NCEH1 (0.47) CYP2A6MAPTALDH1A1MEN1KMT2A
SCHEMBL614621 0.78 PREP (0.47) CYP2A6MAPTALDH1A1MEN1KMT2A
SCHEMBL17881929 0.78 ESR2 (0.39) MAPTALDH1A1KMT2ARAB9AMAPK1
SCHEMBL9714337 0.78 ESR2 (0.39) MAPTALDH1A1KMT2ARAB9AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111617646-B Preparation method of chiral conjugated microporous polymer/silicon dioxide composite membrane 齐齐哈尔大学 2022-03-04 CN claimed
CN-111617646-A Preparation method of chiral conjugated microporous polymer/silicon dioxide composite membrane 齐齐哈尔大学 2020-09-04 CN claimed
US-10385093-B2 Estrogen receptor imaging agents NORTHEASTERN UNIVERSITY (US) 2019-08-20 US claimed
US-20150344518-A1 ESTROGEN RECEPTOR IMAGING AGENTS UNITED STATES DEPARTMENT OF ENERGY 2015-12-03 US claimed
WO-2014093378-A1 ESTROGEN RECEPTOR IMAGING AGENTS NORTHEASTERN UNIVERSITY (US) 2014-06-19 WO claimed
US-11912731-B2 Use of silylated formiates as hydrosilane equivalents COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2024-02-27 US disclosed
CN-114181244-A Preparation method of alkyl siloxy halogenated benzene 宁夏中星显示材料有限公司 2022-03-15 CN disclosed
CN-111617646-B Preparation method of chiral conjugated microporous polymer/silicon dioxide composite membrane 齐齐哈尔大学 2022-03-04 CN disclosed
CN-109912455-B Method for preparing 4-hydroxy-4' -cyanobiphenyl 宁夏中星显示材料有限公司 2022-03-01 CN disclosed
CN-111617646-A Preparation method of chiral conjugated microporous polymer/silicon dioxide composite membrane 齐齐哈尔大学 2020-09-04 CN disclosed
US-10385093-B2 Estrogen receptor imaging agents NORTHEASTERN UNIVERSITY (US) 2019-08-20 US disclosed
US-20150344518-A1 ESTROGEN RECEPTOR IMAGING AGENTS UNITED STATES DEPARTMENT OF ENERGY 2015-12-03 US disclosed
US-5149696-A Antiestrogens ROUSSEL UCLAF (FR) 1992-09-22 US disclosed
EP-0471612-A2 New steroids having an amide substituted group in the 11-beta position, their preparation, their use as medicines and pharmaceutical composition thereof ROUSSEL UCLAF (FR) 1992-02-19 EP disclosed
WO-1991009855-A1 PHARMACEUTICALLY ACTIVE NORMONYL COMPOUNDS BEECHAM GROUP PLC (GB) 1991-07-11 WO disclosed
EP-0384842-A1 19-Nor steroids substituted at position 11-beta by a hydrocarbon chain containing an amide or carbamate group, their preparation, intermediates, their use as medicaments and pharmaceutical compositions containing them ROUSSEL-UCLAF (FR) 1990-08-29 EP disclosed
US-4500628-A IRRADIATING FILM CONSISTING OF POLYMER AND ORGANOSILICON MONOMER AT&T BELL LABORATORIES (US) 1985-02-19 US disclosed
US-4396704-A Solid state devices produced by organometallic plasma developed resists BELL TELEPHONE LABORATORIES, INCORPORATED (US) 1983-08-02 US disclosed
US-3992536-A SEDATIVES AND MUSCLE RELAXANTS BOEHRINGER INGELHEIM GMBH (DT) 1976-11-16 US disclosed
US-3931185-A SEDATIVES, MUSCLE RELAXANT BOEHRINGER INGELHEIM GMBH (DT) 1976-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11912731-B2 Use of silylated formiates as hydrosilane equivalents PFAS, EPM2A, CYP2F1 CYP2A6 483/4885MAPT 666/4885ALDH1A1 112/4885
US-10385093-B2 Estrogen receptor imaging agents ESR1, GPER1, ESR2 CYP2A6 1208/4885MAPT 1851/4885ALDH1A1 1661/4885
US-20150344518-A1 ESTROGEN RECEPTOR IMAGING AGENTS ESR1, GPER1, ESR2 CYP2A6 1208/4885MAPT 1851/4885ALDH1A1 1661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.